Ribeiro A B, Franco R J, Kohlmann O, Marson O, Ramos O L
Clin Exp Hypertens (1978). 1981;3(6):1219-37. doi: 10.3109/10641968109037435.
The blood pressure response to different doses of methylprednisolone was examined in the rat. It is concluded that doses varying from 2.5 mg/kg/week to 20 mg/kg/week of this agent caused clear-cut elevations in arterial pressure. The methylprednisolone-induced arterial hypertension was accompanied by elevation in Plasma Renin Activity and administration of captopril or saralasin caused significant drops in systemic arterial pressure. Concomitant long term administration of captopril and methylprednisolone caused a delay in appearance and smaller elevations in arterial pressure. It is concluded the methylprednisolone in the rat causes arterial hypertension which is at least partially dependent upon renin angiotensin system activation. However elevated blood pressure levels were noticeable even during chronic captopril administration leading to the conclusion that other mechanism (s) may participate in the pathogenesis of this experimental model of hypertension in rats.
在大鼠中研究了不同剂量甲泼尼龙的血压反应。得出的结论是,该药物剂量从2.5毫克/千克/周变化到20毫克/千克/周会导致动脉血压明显升高。甲泼尼龙诱导的动脉高血压伴有血浆肾素活性升高,给予卡托普利或沙拉新可使体循环动脉血压显著下降。卡托普利和甲泼尼龙长期联合给药会导致动脉血压升高出现延迟且升高幅度较小。得出的结论是,大鼠中的甲泼尼龙会导致动脉高血压,这至少部分依赖于肾素 - 血管紧张素系统激活。然而,即使在长期给予卡托普利期间,血压水平仍显著升高,由此得出结论,其他机制可能参与了大鼠这种实验性高血压模型的发病机制。